| Ytd | 62.02% | |
| 1y | 124.08% |
| Open | 9.88 | Prev Close | 9.49 | Low | 9.54 | High | 10.08 | Mkt Cap | 1.65B |
| Vol | 2.03M | Avg Vol | 1.83M | EPS | -1.86 | P/E | -5.25 | Forward P/E | -3.92 |
| Beta | 1.59 | Short Ratio | 12.07 | Inst. Own | 84.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.30 | 200-d Avg | 8.25 | 1yr Est | 21.00 |
VIR News
Vir Biotechnology, Inc. (VIR) Q2 2026 Earnings Call Transcript
Vir Biotechnology (NASDAQ: VIR) reported second-quarter 2026 results alongside updates on its chroni
Vir Biotechnology NASDAQ: VIR reported second-quarter 2026 results alongside updates on its chronic
Vir Biotechnology, Inc. (VIR) came out with quarterly earnings of $0.47 per share, missing the Zacks
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate up
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Brent Sabatini, Senior Vice President and
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Brent Sab
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it will h
Vir Biotechnology is entering a catalyst-rich period with key clinical trial readouts from the ECLIP
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointmen
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company wi
Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborati
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging part
Vir Biotechnology is rated a buy, supported by a strong cash position, pivotal late-stage pipeline,
Vir Biotechnology, Inc. (VIR) Presents at Bank of America Global Healthcare Conference 2026 Transcri
Vir Biotechnology, Inc. (VIR) Q1 2026 Earnings Call Transcript
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate up
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its globa
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
During the session on Thursday, 461 stocks hit new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
On Wednesday, 179 companies reached new 52-week lows.
On Tuesday, 164 companies achieved new lows for the year.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
During Thursday, 849 stocks hit new 52-week lows.